2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody
2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody Detail:
Product details
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by Escherichia coli expression system and the target gene Met1-Ala419 is expressed with 6 HIS tag at the N-terminus. Consists of 428 amino acids and predicts a molecular mass of 46.6 kDa.
Properties
| Purity | ≥95% (SDS-PAGE) |
| Molecular Mass | 46.6 kDa |
| Product Buffer | 20mM PB, 150mM NaCl, 10%Glycerol, pH8.0. |
| Storage | Store at -20℃ to -80℃. Avoid multiple freeze/thaw cycles. |
Order Information
| Product Name | Cat. No | Quantity |
| Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) | AG0046 | Customized |
Product detail pictures:
Related Product Guide:
We emphasize progress and introduce new solutions into the market each year for 2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody , The product will supply to all over the world, such as: Thailand, Danish, Adelaide, Company name, is always regarding quality as company' s foundation, seeking for development via high degree of credibility , abiding by ISO quality management standard strictly, creating top-ranking company by spirit of progress-marking honesty and optimism.
By Judith from kazakhstan - 2018.09.19 18:37
The company account manager has a wealth of industry knowledge and experience, he could provide appropriate program according our needs and speak English fluently.
By Princess from Casablanca - 2017.07.28 15:46
Write your message here and send it to us
